Filter Results:
(622)
Show Results For
- All HBS Web
(1,437)
- People (1)
- News (530)
- Research (622)
- Events (3)
- Multimedia (9)
- Faculty Publications (272)
Show Results For
- All HBS Web
(1,437)
- People (1)
- News (530)
- Research (622)
- Events (3)
- Multimedia (9)
- Faculty Publications (272)
Sort by
- 02 Jul 2009
- Working Paper Summaries
Technology Innovation and Diffusion as Sources of Output and Asset Price Fluctuations
- 24 Feb 2020
- Working Paper Summaries
Recovering Investor Expectations from Demand for Index Funds
- 09 Aug 2004
- Research & Ideas
A Diagnostic for Disruptive Innovation
the draw anymore. By conducting a series of diagnostics, companies in any industry can quickly identify the most promising opportunities. This article shows how to conduct customer, portfolio, and competitor diagnostics to pinpoint the... View Details
- 22 Jan 2016
- Working Paper Summaries
Financial Patent Quality: Finance Patents After State Street
- April 2017
- Case
Imprimis (A)
By: Ramon Casadesus-Masanell, Karen Elterman and Marc Appel
This case examines the strategic choices and evolving business model of Imprimis Pharmaceuticals from the perspective of CEO Mark Baum. The (A) case provides a brief history of the company and of the compounding business, outlining the challenges faced by Imprimis in... View Details
Keywords: Strategy; Healthcare; Drug Compounding; Pharmaceuticals; Compounding; Drug Development; Decision-making; Mark Baum; Imprimis; Small Business; Decisions; Cost vs Benefits; Business Strategy; Business Model; Decision Choices and Conditions; Pharmaceutical Industry; United States
Casadesus-Masanell, Ramon, Karen Elterman, and Marc Appel. "Imprimis (A)." Harvard Business School Case 717-426, April 2017.
- April 2006
- Article
The Conditional Nature of Embeddedness: Borrowing by Large U.S. Firms, 1973-1994
By: Mark S. Mizruchi, Linda Brewster Stearns and Christopher Marquis
Mizruchi, Mark S., Linda Brewster Stearns, and Christopher Marquis. "The Conditional Nature of Embeddedness: Borrowing by Large U.S. Firms, 1973-1994." American Sociological Review 71, no. 2 (April 2006): 406–409.
- 2012
- Report
Competing by Saving Lives: How Pharmaceutical and Medical Device Companies Create Shared Value in Global Health
By: Mark R. Kramer, Kyle Peterson, Matthew Rehrig, Mike Stamp and Samuel Kim
Examples of how pharmaceutical and medical companies are addressing unmet health needs in low- and middle- income economies, creating shared value by providing products and services that tackle global health problems. View Details
Keywords: Shared Value; Low- And Middle-income Economies; Health Care and Treatment; Global Range; Pharmaceutical Industry; Medical Devices and Supplies Industry
Kramer, Mark R., Kyle Peterson, Matthew Rehrig, Mike Stamp, and Samuel Kim. "Competing by Saving Lives: How Pharmaceutical and Medical Device Companies Create Shared Value in Global Health." Report, FSG, 2012.
- 17 Dec 2018
- Research & Ideas
Women Receive Harsher Punishment at Work Than Men
afterwards, their employment prospects were pretty dismal,” says Mark Egan, an assistant professor of finance at Harvard Business School. Egan details the misconduct findings in a new working paper, “When Harry Fired Sally: The Double... View Details
- 23 Mar 2023
- Research & Ideas
As Climate Fears Mount, More Investors Turn to 'ESG' Funds Despite Few Rules
Investor interest in social responsibility has skyrocketed in the past three years, even as US regulations to hold companies accountable remain in flux and the environmental, social, and governance (ESG) label itself draws backlash. Investors are willing to pay a... View Details
- 16 Feb 2023
- HBS Case
ESG Activists Met the Moment at ExxonMobil, But Did They Succeed?
The impact-investment hedge fund Engine No. 1 made a big splash in May 2021 when it managed to get three nominees elected to the ExxonMobil board of directors. It was an open effort to prod the oil giant toward renewable energy and test whether activist investing could... View Details
- Fall 2018
- Book Review
Are the Elite Hijacking Social Change? Review of Winners Take All, by Anand Giridharadas
By: Mark R. Kramer
Kramer, Mark R. "Are the Elite Hijacking Social Change? Review of Winners Take All, by Anand Giridharadas." Stanford Social Innovation Review 16, no. 4 (Fall 2018): 68–70.
- Summer 2020
- Book Review
Big Structural Change: Review of Reimagining Capitalism in a World on Fire, by Rebecca Henderson
By: Mark R. Kramer
Kramer, Mark R. "Big Structural Change: Review of Reimagining Capitalism in a World on Fire, by Rebecca Henderson." Stanford Social Innovation Review 18, no. 3 (Summer 2020): 67–69.
- Book Review
Book Review of "How to Change the World," by David Bornstein, Oxford University Press, 2004
By: Mark R. Kramer
Kramer, Mark R. Book Review of "How to Change the World," by David Bornstein, Oxford University Press, 2004. Stanford Social Innovation Review 2, no. 1 (Summer 2004): 77.
- 18 Oct 2004
- Research & Ideas
The Bias of Wall Street Analysts
up until the point (and even after) the company tumbled off a cliff. Indeed, HBS professor Mark Bradshaw and collaborators Scott Richardson and Richard Sloan found that pre-year 2000 forecasts and recommendations done View Details
- 08 Jan 2018
- Research & Ideas
The Startling Percentage of Financial Advisors with Misconduct Records
required to disclose any whiff of misbehavior to the Financial Industry Regulatory Authority (FINRA), an independent monitoring organization regulated by the Securities and Exchange Commission. A research team examined those records to... View Details
- 30 Jul 2024
- Research & Ideas
Do Social Movements Sway Voters? Not Really, Except for One
important implications in an election year marked by widespread protests. Harvard Business School Professor Vincent Pons teamed up with Amory Gethin, a fellow economist at the World Bank Development Research... View Details
Keywords: by Sean Silverthorne
- 12 Aug 2020
- Research & Ideas
Why Investors Often Lose When They Sue Their Financial Adviser
indexes by 30 percent. The market swings likely prompted many brokerage customer to scrutinize their advisers’ investments, and some might not have liked what they saw. “There's a Warren Buffett quote: ‘Only when the tide goes out do you... View Details
- December 2017
- Article
Overall Cost Comparison of Gastrointestinal Endoscopic Procedures with Endoscopist- or Anesthesia-Supported Sedation by Activity-Based Costing Techniques
By: Richard A. Helmers, James A. Dilling, Christopher R. Chaffee, Mark V. Larson, Bradly J. Narr, Derek A. Haas and Robert S. Kaplan
Endoscopic/Colonoscopic procedures are done either with gastroenterologist-administered conscious sedation or with anesthesia-administered sedation with propofol. Anesthesia-administered sedation has medical and patient benefits but is more expensive to administer. We... View Details
Helmers, Richard A., James A. Dilling, Christopher R. Chaffee, Mark V. Larson, Bradly J. Narr, Derek A. Haas, and Robert S. Kaplan. "Overall Cost Comparison of Gastrointestinal Endoscopic Procedures with Endoscopist- or Anesthesia-Supported Sedation by Activity-Based Costing Techniques." Mayo Clinic Proceedings: Innovations, Quality & Outcomes 1, no. 3 (December 2017): 234–241.
- Spring 2017
- Book Review
Collaborative Cues: Review of Conscious Collaboration: Re-thinking the Way We Work Together, for Good, by Ben Emmens
By: Mark R. Kramer
Kramer, Mark R. "Collaborative Cues: Review of Conscious Collaboration: Re-thinking the Way We Work Together, for Good, by Ben Emmens." Stanford Social Innovation Review 15, no. 2 (Spring 2017).